Advanced ROS1-positive NSCLC

Advanced ROS1-positive NSCLC

Optimizing Molecular Testing to Identify Driver Mutations in Advanced Non–Small Cell Lung Cancer

expert roundtables
By D. Ross Camidge, MD, PhD; Mark A. Socinski, MD; Heather Wakelee, MD, FASCO

Advanced ROS1-positive NSCLC

Expert Roundtables Podcast: Next-Generation Tyrosine Kinase Inhibitors for ROS1-Positive Non–Small Cell Lung Cancer

expert roundtables
By D. Ross Camidge, MD, PhD; Mark A. Socinski, MD; Heather Wakelee, MD, FASCO

Advanced ROS1-positive NSCLC

Molecular Testing in Advanced Non–Small Cell Lung Cancer: Detecting Complex Rearrangements

clinical topic updates
By Heather Wakelee, MD, FASCO

Advanced ROS1-positive NSCLC

From Mutation to Decision: Personalized Care Choices in Advanced ROS1-Positive Non–Small Cell Lung Cancer

patient care perspectives
By Heather Wakelee, MD, FASCO

Advanced ROS1-positive NSCLC

The Biology and Clinical Course of Advanced ROS1-Positive Non–Small Cell Lung Cancer

clinical topic updates
By D. Ross Camidge, MD, PhD